Artificial intelligence software company Thirona has released PRAGMA-AI, technology that automates and accelerates CT scans in cystic fibrosis analysis.
Formerly Parexel Informatics, the renamed clinical research technology company has broken off and will operate as an independent company going forward.
BioClinica has acquired MDDX Research and Informatics to provide sponsors and CROs access to medical imaging technology, which can determine patient clinical trial eligibility in under an hour, says founder.
The new Princeton, NJ-based office is the result of a multimillion-dollar investment and continued growth driven by an increasing use of medical imaging in clinical research.
Invicro has acquired Imanova in a move that bolsters the company’s biomedical imaging capabilities and gives it a foothold to expand its services into Europe.
BioClinica has opened offices in London and Munich to provide its European clients with expanded clinical trial services including medical imaging, site training and support, and eClinical product lines.
Contract research organisation (CRO) Maccine will set up a preclinical imaging laboratory in partnership with the Singapore Bioimaging Consortium (SBIC) under a deal announced late last week.
Outsourcing-pharma takes a look at all the latest developments in the rapidly expanding drug development imaging sector with news from Aspect and Medisco, VirtualScopics and ABX-CRO and ACR Image Metrix.
Perceptive Informatics has added industry standard performance metrics to its medical imaging capabilities, allowing users to track progress against Metrics Champion Consortium (MCC) criteria.
Perceptive Informatics has expanded its offering for trials involving Alzheimer's disease with a new medical imaging method, which it claims produces higher quality, reproducible and regulatory compliant assessments.
Parexel’s eClinical subsidiary Perceptive Informatics has entered into an alliance with AG Mednet to improve the efficiency and quality of the electronic image transfer process.
Charles River Laboratories has agreed to buy US-based drug discovery imaging expert Molecular Imaging Research, Inc. (MIR) for approximately $12.5m (€8.8m) in cash.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving Parexel, Chiltern,
Accelovance and Icon.
VirtualScopics reported a breakthrough year in 2005, doubling its
customer base to 26 and reaping in more than $5 m (€4.1 m) worth of
business, an increase from the previous year of over 100 per cent.
The use of positron emission tomography (PET) and small animal
imaging has the potential to eliminate more strenuous drug
development trials with animals, creating a viable alternative.
